Company: DMAC
Filing Date: 2025-07-21
Form Type: 8-K
Source: 0001437749-25-023048
Chunk: 2

Company: DiaMedica Therapeutics Inc.
Filing Date: 2025-07-21
Form: 8-K
Item: Item 3.02
Chunk 2
---
Item 3.02      Unregistered Sales of Equity Securities.  

The information provided in Item 1.01 of this Current Report on Form 8-K is hereby incorporated by reference into this Item 3.02. Based in part on the representations of the Purchasers in the Securities Purchase Agreement, the offering and sale of the Shares will be exempt from registration under Section 4(a)(2) of the United States Securities Act of 1933, as amended (the “ Securities Act”), and Rule 506 of Regulation D as promulgated thereunder. The sale of the Shares did not involve a public offering and was made without general solicitation or general advertising. The Purchasers have represented that they are accredited investors, as such term is defined in Rule 501(a) of Regulation D under the Securities Act, and they are acquiring the Shares for investment purposes only and not with a view to any resale, distribution or other disposition of the Shares in violation of the United States federal securities laws.

Neither this Current Report on Form 8-K nor any exhibit attached hereto is an offer to sell or the solicitation of an offer to buy the Company’s common shares or other securities of the Company.